Prostate cancer metastatic Trials in London, United Kingdom
Conditions / Prostate cancer metastatic / London, United Kingdom
Prostate cancer metastatic is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04478279 | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT06136624 | Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | RECRUITING | PHASE3 |
| NCT03850795 | HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) | TERMINATED | PHASE3 |
| NCT03436485 | Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT06320067 | A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer | RECRUITING | PHASE3 |
| NCT04400656 | PROState Pathway Embedded Comparative Trial | COMPLETED | — |
| NCT05177042 | Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer | COMPLETED | — |
| NCT01254279 | Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen | COMPLETED | PHASE3 |
| NCT04590976 | Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research | COMPLETED | — |
| NCT01322490 | A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer | COMPLETED | PHASE3 |